Kurt Brorson, Ph.D. is Vice President, Technical, at PAREXEL Consulting where he provides a full range of consulting services for the quality of biopharmaceuticals, with specific expertise in biomanufacturing, therapeutic monoclonal antibodies, biosimilars and viral safety/viral clearance. He also acts as a trusted advisor to clients, often on issues that lack precedent or are not clearly defined.
Prior to joining PAREXEL, Dr. Brorson was a Lab Chief in CDER/OPQ/Office of Biotechnology Products (OBP) at the FDA. Dr. Brorson received his BA. in Biology from University of...Read more